24/7 Market News Snapshot 27 March, 2025 – Quantum Biopharma Ltd. Class B Subordinate Voting Shares (NASDAQ:QNTM)

March 27, 2025

DENVER, Colo., 27 March, 2025 (247marketnews.com) – (NASDAQ:QNTM) are discussed in this article.
Quantum BioPharma Ltd. (NASDAQ:QNTM) commenced trading today at $7.36 and has seen a significant rise, currently at $7.875, reflecting an increase of 13.31% after closing the previous session at $6.95. This upward momentum highlights strong investor interest, with a current trading volume of 862.92K shares. The price surpassing both the opening and previous close levels suggests potential for continued gains, while support may be established around $7.36 and resistance near $8.00. Traders are encouraged to monitor volume trends as they may indicate the sustainability of this price movement amidst broader market fluctuations.

In addition to its promising stock performance, Quantum BioPharma has announced the appointment of Terry Lynch to its board of directors, effective immediately, after Dr. Sanjiv Chopra’s resignation. Lynch, a well-respected leader in the biopharmaceutical sector, brings extensive experience in fostering market transparency and tackling market manipulation. Currently the CEO of Power Metallic Mines Inc., he has successfully led a $50 million financing initiative and co-founded Cardiol Therapeutics, focusing on innovative treatments for cardiovascular diseases.

Zeeshan Saeed, CEO of Quantum BioPharma, expressed his excitement over Lynch’s appointment, emphasizing his capability to raise capital in challenging environments and understanding of biotech investments. This strategic move is poised to enhance the company’s governance and support its ongoing legal efforts related to market integrity.

To commemorate Lynch’s new role, Quantum BioPharma has awarded him 50,000 stock options at an exercise price of C$9.90 per share, expiring on March 26, 2027. With these developments, Quantum BioPharma is well-positioned to advance its groundbreaking research initiatives aimed at addressing metabolic and neurodegenerative disorders while enhancing value for its shareholders.

Related news for (QNTM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.